DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
van der Wall SJ, van Rein N, van den Bemt B. , et al.
Performance of idarucizumab as antidote of dabigatran in daily clinical practice.
Europace 2019;
21 (03) 414-420
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.